Dan Groman, Chief Technology Officer at Enfusion, Inc. (ENFN), sold 3,877 shares at $10.93 ($42K) on 2023-02-17, disclosed to the SEC on 2023-02-22.
Scheduled sale ($42k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ENFN | SELL | 2023-09-21 | $45K | — | Filing → |
| ENFN | SELL | 2023-08-15 | $14K | — | Filing → |
| ENFN | SELL | 2023-08-14 | $15K | — | Filing → |